UVA offers an updated, more conformal version of the recommended combination therapy, which includes high-dose rate brachytherapy, intensity-modulated radiation therapy and use of a prostate-rectal spacer.
Category: Cancer (Page 8)
UVA Cancer Center is now offering breast cancer patients a treatment that has been shown to limit hair loss. DigniCap is a scalp cooling treatment that has been FDA-approved for patients with solid tumors.
With three community oncology clinic locations, UVA Cancer Center offers advanced medical oncology and hematology care throughout the Commonwealth.
Leaders in cancer research and cancer care have issued a call to action for physicians, parents and young adults to increase vaccination rates to eliminate HPV-related cancers.
A recipient of the 2016 Rising Star in Oncology award from the Society for Translational Medicine, Reilley has set his sights on improving the future of cancer care through clinical trials.
New ACR Appropriateness Criteria added unprecedented depth to what had been a much more modest overview, providing physicians an easy way to catch up with the latest developments and stay at the very forefront of best practices.
The Phase II study has enrolled 120 women ages 45 and older with stage 0 or stage 1 breast cancer. Recruitment is ongoing at UVA and the study is now enrolling participants at Thomas Jefferson University in Philadelphia as well.
Women with dense or homogeneous dense breast tissue should consider an alternate form of breast cancer screening beyond traditional mammography.
As part of its ongoing mission to expand and optimize its clinical research infrastructure and provide patients access to the most advanced cancer treatment and prevention strategies available, UVA Cancer Center welcomes two world-class clinicians and researchers to grow its bone marrow transplant program.
A UVA study revealed that most women don’t know that having dense breast tissue increases their risk for cancer and reduces a mammogram’s ability to detect it.